Blog

Okta (NASDAQ: OKTA) investors have some big questions heading into its first-quarter earnings report in a few days. The stock of the identity-management software specialist has dropped in recent

Verizon (NYSE: VZ) and AT&T (NYSE: T) have both long been considered reliable dividend stocks for conservative investors. But over the past decade, Verizon stock generated a total return of more

Recent retirees should ignore all the noise about cryptocurrencies, NFTs, SPACs, and other speculative investments. Some of these investments might generate big short-term gains, but they're far too

The price of the world's largest cryptocurrency, Bitcoin (CRYPTO: BTC), has dropped 37% from its all-time high. As of this writing, it's trading hands at around $41,000 per token. By contrast, the

When Target (NYSE: TGT) sold its 1,647 pharmacies to CVS Health (NYSE: CVS) in 2015, many wondered why two companies that seemed like competitors would create a partnership. The two CEOs didn't

In the Ice Age, mammoths were fabulous beasts of their time -- so much so that some geneticists are pursuing their revival by using new technology, such as writing DNA, to clone them back into

At Berkshire Hathaway's (NYSE: BRK.A)(NYSE: BRK.B) latest annual meeting, Warren Buffett had some not-so-kind things to say about the Robinhood stock trading platform. In this Fool Live video clip

You're probably aware that saving for retirement is crucial, and if you didn't know that, here's a gentle but necessary wake-up call. Social Security will only replace about 40% of your

Novavax (NASDAQ: NVAX) recently announced that it's changing the protocol for its pivotal late-stage study of COVID-19 vaccine candidate NVX-CoV2373. In this Motley Fool Live video recorded on May

NVIDIA (NASDAQ: NVDA) has been one of the best performers in the tech sector in recent years as its name has become synonymous with artificial intelligence, self-driving cars, cloud computing, and

Even as the major market indexes are topping fresh highs, there are plenty of great growth stocks out there that have been punished as some investors have turned their focus to "recovery" stocks

The electrification of the automotive industry has hit the fast lane, and for that we have Tesla (NASDAQ: TSLA) to thank.

The company and its CEO Elon Musk are at times lightning rods for

Shares of Iovance Biotherapeutics (NASDAQ: IOVA) have been on a roller-coaster ride over the past few days. That's likely because investors don't know what to make of press releases that don't quite

If you invested $10,000 into BioNTech (NASDAQ: BNTX) stock upon its October 2019 IPO, that principal would have turned to about $125,800 as of May 21, 2021. That is several magnitudes better than

On Wall Street, Warren Buffett, the CEO of Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), is an investing icon. Since taking the helm more than five decades ago, he's led his company's share price

When it comes to biotech companies, a bird in the hand is not always worth two in the bush for shareholders. A steady drumbeat of good news from clinical-stage projects in the pipeline often makes

In the past year, Vertex Pharmaceuticals' (NASDAQ: VRTX) stock price has fallen by 24%. That is a particularly disappointing performance, especially considering the S&P 500 rose by 40% over the same

Here's the reality: Dogecoin (CRYPTO: DOGE) could make you a fortune, possibly even enough to retire depending on how much you already have saved. But the odds of that happening are pretty slim. And

The U.S. equity market has been quite volatile over the past few weeks. The first three days of last week saw tech stocks falling on fears of increasing inflation and a faster-than-anticipated

There's no time like the present for biotech stocks, especially those of companies engaged in coronavirus vaccine development. Between the yet-to-be-contained pandemic and a newfound global

With COVID-19 dominating the world's healthcare concerns for the past year and change, people have been letting a lot of other potential medical concerns slide. One result of that: a drop-off in

Last year's market crash -- fueled by fears of the pandemic's effects on the economy -- turned out to be a great buying opportunity for investors. Since the market bottomed out in late March 2020

For the past 14 months, investors have enjoyed the strongest bounce back from a bear market bottom in history. After losing 34% of its value in just 33 calendar days during the first quarter of

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) recently won U.S. Emergency Use Authorization (EUA) for their COVID-19 vaccine for adolescents ages 12 to 15. In this Motley Fool Live video recorded

Afterpay (OTC:AFTP.F) is one of the world's leading providers of buy-now-pay-later (BNPL) technology, which is an increasingly popular service that allows consumers to break purchases into four